单细胞转录组分析识别系统性硬化症皮肤特异性T细胞应答
该研究对27例活动性SSc患者和10名健康供者的皮肤活检进行10x Genomics液滴单细胞RNA测序,聚焦3729个CD3+淋巴细胞(正常皮肤867个、SSc皮肤2862个)。研究发现SSc皮肤中存在独特的循环CXCL13+ T细胞群,表达滤泡辅助性T细胞样基因签名,可能促进炎症皮肤内的B细胞应答;共聚焦免疫荧光验证了转录结果并显示T细胞亚群的空间定位。
要点
- SSc皮肤中存在独特的循环CXCL13+ T细胞群,具滤泡辅助性T细胞样基因表达签名。
- 该亚群可能促进SSc炎症皮肤内的B细胞应答。
- 单细胞转录组可解析患者特异性T细胞异质性,为选择性靶向异常免疫应答提供依据。
核心结论
- SSc皮肤中存在独特的循环CXCL13+ T细胞群,表达滤泡辅助性T细胞样签名,可能促进炎症皮肤内B细胞应答。
- 识别驱动SSc发病的精确免疫机制可能带来选择性靶向异常免疫应答的创新疗法,从而疗效更好、毒性更小。
研究设计与样本
- 对27例活动性SSc患者和10名健康供者的皮肤活检行10x Genomics液滴单细胞RNA测序,聚焦3729个CD3+淋巴细胞(正常皮肤867个、SSc皮肤2862个)。
- 对进行性SSc皮肤样本行共聚焦免疫荧光显微镜检查,验证转录结果并可视化T细胞亚群的空间定位。
主要发现
- 在健康与SSc皮肤中识别出多个再循环和组织驻留T细胞亚群,分别关联不同信号通路。
- 多数细胞簇在患者与对照间共享共同基因表达签名。
- SSc皮肤中识别出独特的循环CXCL13+ T细胞簇,表达滤泡辅助性T细胞样基因表达签名。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Although T cells have been implicated in the pathogenesis of systemic sclerosis (SSc), a comprehensive study of T-cell-mediated immune responses in the affected skin of patients with progressive SSc is lacking. Droplet-based single-cell transcriptome analysis of SSc skin biopsies opens avenues for dissecting patient-specific T-cell heterogeneity, providing a basis for identifying novel gene expression related to functional pathways associated with severity of SSc skin disease. METHODS: Single-cell RNA sequencing was performed by droplet-based sequencing (10x Genomics), focusing on 3729 CD3+ lymphocytes (867 cells from normal and 2862 cells from SSc skin samples) from skin biopsies of 27 patients with active SSc and 10 healthy donors. Confocal immunofluorescence microscopy of progressive SSc skin samples validated transcriptional results and visualised spatial localisations of T-cell subsets. RESULTS: We identified several subsets of recirculating and tissue-resident T cells in healthy and SSc skin that were associated with distinct signalling pathways. While most clusters shared a common gene expression signature between patients and controls, we identified a unique cluster of recirculating CXCL13+ T cells in SSc skin which expressed a T helper follicular-like gene expression signature and that appears to be poised to promote B-cell responses within the inflamed skin of patients. CONCLUSIONS: Current available therapies to reverse or even slow progression of SSc lead to broad killing of immune cells and consequent toxicities, including death. Identifying the precise immune mechanism(s) driving SSc pathogenesis could lead to innovative therapies that selectively target the aberrant immune response, resulting in better efficacy and less toxicity.
引用
- Gaydosik AM, Tabib T, Domsic R, et al. Single-cell transcriptome analysis identifies skin-specific T-cell responses in systemic sclerosis. Ann Rheum Dis. 2021. PMID: 34031030. doi:10.1136/annrheumdis-2021-220209
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。